{"title":"Hypothesized and found mechanisms for potentiation of bradykinin actions.","authors":"Sylvia Mueller, Inge Paegelow, Siegmund Reissmann","doi":"10.1002/sita.200500061","DOIUrl":null,"url":null,"abstract":"<p><p>Potentiation of hormone actions can occur by different mechanisms, including inhibition of degrading enzymes, interaction with the hormone receptor leading to stabilization of bioactive conformation or leading to receptor homo- and hetero-oligomerization, receptor phosphorylation and dephosphorylation or can occur by directly influencing the signal transduction and ion channels. In this review the potentiation of bradykinin actions in different systems by certain compounds will be reviewed. Despite many long years of experimental research and investigation the mechanisms of potentiating action remain not fully understood. One of the most contradictory findings are the distinct differences between the inhibition of the angiotensin I-converting enzyme and the potentiation of the bradykinin induced smooth muscle reaction. Contradictory findings and hypothesized mechanisms in the literature are discussed in this review and in some cases compared to own results. Investigation of potentiating actions was extended from hypotension, smooth muscle reaction and cellular actions to activation of immunocompetent cells. In our opinion the potentiation of bradykinin action can occur by different mechanisms, depending on the system and the applied potentiating factor used.</p>","PeriodicalId":88702,"journal":{"name":"Signal transduction","volume":"6 1","pages":"5-18"},"PeriodicalIF":0.0000,"publicationDate":"2006-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169587/pdf/SITA-6-5.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Signal transduction","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/sita.200500061","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2006/1/17 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Potentiation of hormone actions can occur by different mechanisms, including inhibition of degrading enzymes, interaction with the hormone receptor leading to stabilization of bioactive conformation or leading to receptor homo- and hetero-oligomerization, receptor phosphorylation and dephosphorylation or can occur by directly influencing the signal transduction and ion channels. In this review the potentiation of bradykinin actions in different systems by certain compounds will be reviewed. Despite many long years of experimental research and investigation the mechanisms of potentiating action remain not fully understood. One of the most contradictory findings are the distinct differences between the inhibition of the angiotensin I-converting enzyme and the potentiation of the bradykinin induced smooth muscle reaction. Contradictory findings and hypothesized mechanisms in the literature are discussed in this review and in some cases compared to own results. Investigation of potentiating actions was extended from hypotension, smooth muscle reaction and cellular actions to activation of immunocompetent cells. In our opinion the potentiation of bradykinin action can occur by different mechanisms, depending on the system and the applied potentiating factor used.
荷尔蒙作用的增效可以通过不同的机制发生,包括抑制降解酶、与荷尔蒙受体相互作用导致生物活性构象稳定化或导致受体同源和异源偶联化、受体磷酸化和去磷酸化,或者直接影响信号转导和离子通道。本综述将对某些化合物在不同系统中对缓激肽作用的增效作用进行综述。尽管经过多年的实验研究和调查,人们对缓激肽的增效作用机制仍不完全清楚。最矛盾的发现之一是,对血管紧张素 I 转化酶的抑制作用与缓激肽诱导平滑肌反应的增效作用之间存在明显差异。本综述讨论了文献中相互矛盾的发现和假设的机制,并在某些情况下与自己的研究结果进行了比较。对缓激肽增效作用的研究范围从降压、平滑肌反应和细胞作用扩展到免疫细胞的激活。我们认为,缓激肽的增效作用可以通过不同的机制发生,这取决于所使用的系统和增效因子。